abs145.txt	treatment	of	hepatocellular	carcinoma	(hcc)	requires	sustained	suppression	oftumor	cell	growth	and	metastasis	for	long-term	efficacy		however		traditionalintratumoral	drug	delivery	system	always	exhibits	burst	release	with	lesstherapeutic	outcomes		here		a	new	self-assembling	amphiphilic	peptide	drugconjugate	(saapdc)	is	fabricated	as	a		two-in-one		nanofiber	system	comprising	ahexapeptide	as	a	matrix	metalloproteinases	(mmp)	inhibitor	and	doxorubicin	(dox)for	the	treatment	of	hcc		the	results	indicate	that	doxorubicin-conjugatedpeptide	(dox-kgfrwr)	self-assembles	to	form	long	nanofibers	showing	sustainedrelease	property	for	inhibiting	the	enzymatic	activities	of	mmp-2	and	mmp-9		thisnanofiber	not	only	inhibits	tumor	growth	in	situ	but	also	effectively	preventspulmonary	metastasis	in	an	smmc7721	cell	line-based	mouse	model		in	summary		thishexapeptide-based	supermolecule	system	represents	a	promising	nanoscale	platformto	sustain	drug	release	with	high	loading	capacity	for	intratumoraladministration		moreover		the	delivery	of	chemotherapeutic	drugs	via	drug-bearingsupramolecular	mmp	inhibitor	nanofibers	simultaneously	inhibits	metastasis	andtumor	growth	to	achieve	synergistic	effects	for	metastatic	hcc	therapy	
